Detection of a Shiga toxin- and extended-spectrum-β-lactamase-producing Escherichia coli o157: H7 human clinical isolate

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 5, 2013, Pages 1203-1204

  Torpdahl, Mia ^a   Nielsen, Eva M ^a   Scheutz, Flemming ^a   Olesen, Bente ^b   Hansen, Dennis S ^b   Hasman, Henrik ^c  

^a STATENS SERUM INSTITUT   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

E. coli; ESBLs; STEC

Indexed keywords

AMPICILLIN; CEFALOTIN; CEFTIOFUR; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BLOODY DIARRHEA; DIARRHEA; EPIDEMIC; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FECES ANALYSIS; GASTROINTESTINAL INFECTION; GENE; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; REPLICON; SEROTYPE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; WILD TYPE;

ANIMALS; BETA-LACTAMASES; CHILD, PRESCHOOL; DENMARK; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FEMALE; HUMANS; SHIGA TOXIN;

EID: 84877105702     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks516     Document Type: Letter

References (10)

1. Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 1998; 11: 450-79.
2. Carattoli A. Animal reservoirs for extended spectrum β-lactamase producers. Clin Microbiol Infect 2008; 14 Suppl 1: 117-23.
3. Roest HI, Liebana E, Wannet W et al. [Antibiotic resistance in Escherichia coli O157 isolated between 1998 and 2003 in The Netherlands]. Tijdschr Diergeneeskd 2007; 132: 954-8.
4. 1)-positive Escherichia coli O26:H11: a new concern. J Clin Microbiol 2005; 43: 1072-5.
5. Kon M, Kurazono T, Ohshima M et al. [Cefotaxime-resistant Shiga toxin-producing Escherichia coli O26:H11 isolated from a patient with diarrhea]. Kansenshogaku Zasshi 2005; 79: 161-8.
6. Frank C, Werber D, Cramer JP et al. Epidemic profile of Shiga-toxinproducing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 2011; 365: 1771-80.
7. Statens Serum Institut. VTEC outbreak. Epi-Nyt 2004; Week 25. http://www.ssi.dk/Aktuelt/Nyhedsbreve/EPI-NYT/~/media/Indhold/DK%20-%20dansk/Aktuelt/Nyhedsbreve/EPI-NYT/EPI-NYT-Arkiv/2004/2004%20pdf/EPI-NYT%20-%202004%20-%20uge%2025.ashx (7 January 2013, date last accessed).
8. Carattoli A, Bertini A, Villa L et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63: 219-28.
9. Vinue L, Saenz Y, Martinez S et al. Prevalence and diversity of extended-spectrum β-lactamases in faecal Escherichia coli isolates from healthy humans in Spain. Clin Microbiol Infect 2009; 15: 954-7.
10. Rodrigues C, Shukla U, Jog S et al. Extended-spectrum β-lactamaseproducing flora in healthy persons. Emerg Infect Dis 2005; 11: 981-2.